![5d0debcd-](https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2018/09/1200/675/2016-11-15T062338Z_1_LYNXMPECAE094_3_USA-FDA-CASES.jpg?ve=1&tl=1)
The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel (Copyright Reuters 2016)
ZURICH – Roche has launched a global cancer immunotherapy Centers of Research Excellence network, saying it will invest up to 100 million Swiss francs ($100.3 million) in the project.
The research network of 21 academic centers around the world is intended to support basic and clinical research collaboration to advance the science of cancer immunotherapy, the Basel-based drugmaker said on Tuesday.